The US Food and Drug Administration on Tuesday approved Hemgenix, a new drug to treat hemophilia. Manufacturer CSL Behring set the price at $3.5 million per treatment, making it the most expensive drug in the world.

(SOURCE) https://www.cnn.com/2022/11/23/health/hemophilia-drug-hemgenix/index.html